CN101949925A - Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method - Google Patents
Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method Download PDFInfo
- Publication number
- CN101949925A CN101949925A CN2010105163581A CN201010516358A CN101949925A CN 101949925 A CN101949925 A CN 101949925A CN 2010105163581 A CN2010105163581 A CN 2010105163581A CN 201010516358 A CN201010516358 A CN 201010516358A CN 101949925 A CN101949925 A CN 101949925A
- Authority
- CN
- China
- Prior art keywords
- prednisone acetate
- derivant
- gold
- solution
- prednisone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MOVRKLZUVNCBIP-RFZYENFJSA-N cortancyl Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O MOVRKLZUVNCBIP-RFZYENFJSA-N 0.000 title claims abstract description 67
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 238000012360 testing method Methods 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000001514 detection method Methods 0.000 claims abstract description 22
- 239000000427 antigen Substances 0.000 claims abstract description 15
- 102000036639 antigens Human genes 0.000 claims abstract description 15
- 108091007433 antigens Proteins 0.000 claims abstract description 15
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 13
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 13
- 239000000835 fiber Substances 0.000 claims abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 72
- 241001597008 Nomeidae Species 0.000 claims description 60
- 239000000243 solution Substances 0.000 claims description 37
- 239000010931 gold Substances 0.000 claims description 33
- 229910052737 gold Inorganic materials 0.000 claims description 33
- 239000000084 colloidal system Substances 0.000 claims description 30
- 239000000376 reactant Substances 0.000 claims description 30
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 27
- 239000007787 solid Substances 0.000 claims description 21
- 230000008878 coupling Effects 0.000 claims description 18
- 238000010168 coupling process Methods 0.000 claims description 18
- 238000005859 coupling reaction Methods 0.000 claims description 18
- 238000002372 labelling Methods 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 15
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 15
- 210000004681 ovum Anatomy 0.000 claims description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 230000000274 adsorptive effect Effects 0.000 claims description 12
- 229940098773 bovine serum albumin Drugs 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 12
- 241001494479 Pecora Species 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229920004934 Dacron® Polymers 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 9
- 239000012460 protein solution Substances 0.000 claims description 9
- 239000013049 sediment Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 206010003445 Ascites Diseases 0.000 claims description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 5
- 239000000020 Nitrocellulose Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 229920001220 nitrocellulos Polymers 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 240000005373 Panax quinquefolius Species 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 3
- 238000010009 beating Methods 0.000 claims description 3
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002159 nanocrystal Substances 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 3
- 229940038773 trisodium citrate Drugs 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 229960004618 prednisone Drugs 0.000 claims 1
- -1 prednisone acetates Chemical class 0.000 claims 1
- 239000003550 marker Substances 0.000 abstract description 2
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 229920000728 polyester Polymers 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 230000000007 visual effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 21
- 239000003814 drug Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 230000028993 immune response Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010001324 Adrenal atrophy Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 101100495256 Caenorhabditis elegans mat-3 gene Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 208000037171 Hypercorticoidism Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 201000005255 adrenal gland hyperfunction Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010516358 CN101949925B (en) | 2010-10-22 | 2010-10-22 | Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010516358 CN101949925B (en) | 2010-10-22 | 2010-10-22 | Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101949925A true CN101949925A (en) | 2011-01-19 |
CN101949925B CN101949925B (en) | 2013-07-31 |
Family
ID=43453499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010516358 Active CN101949925B (en) | 2010-10-22 | 2010-10-22 | Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101949925B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109324183A (en) * | 2018-11-23 | 2019-02-12 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | A kind of glucocorticoid immunochromatography wide spectrum detection card and the preparation method and application thereof |
CN116462729A (en) * | 2023-03-31 | 2023-07-21 | 华南农业大学 | Prednisone acetate hapten, artificial antigen and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1807601A (en) * | 2006-01-09 | 2006-07-26 | 华中农业大学 | Immune colloid gold test paper strip for detecting sulfadiazine residue and its preparation method |
CN1907953A (en) * | 2005-08-04 | 2007-02-07 | 曾立波 | Monoclonal antibody for ketamine detection and immune detection board |
CN101666799A (en) * | 2009-07-23 | 2010-03-10 | 江苏省农业科学院 | Test strip for detecting colibacillus O157:H7 mouse serum antibody by colloidal gold immunochromatography |
CN101813697A (en) * | 2010-04-09 | 2010-08-25 | 厦门出入境检验检疫局检验检疫技术中心 | Broad-spectrum pesticide residue immunity test strip and preparation method and application thereof |
CN201583543U (en) * | 2010-01-11 | 2010-09-15 | 四川大学华西第二医院 | Test tool and test case for quickly testing premature rupture of membranes |
-
2010
- 2010-10-22 CN CN 201010516358 patent/CN101949925B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1907953A (en) * | 2005-08-04 | 2007-02-07 | 曾立波 | Monoclonal antibody for ketamine detection and immune detection board |
CN1807601A (en) * | 2006-01-09 | 2006-07-26 | 华中农业大学 | Immune colloid gold test paper strip for detecting sulfadiazine residue and its preparation method |
CN101666799A (en) * | 2009-07-23 | 2010-03-10 | 江苏省农业科学院 | Test strip for detecting colibacillus O157:H7 mouse serum antibody by colloidal gold immunochromatography |
CN201583543U (en) * | 2010-01-11 | 2010-09-15 | 四川大学华西第二医院 | Test tool and test case for quickly testing premature rupture of membranes |
CN101813697A (en) * | 2010-04-09 | 2010-08-25 | 厦门出入境检验检疫局检验检疫技术中心 | Broad-spectrum pesticide residue immunity test strip and preparation method and application thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109324183A (en) * | 2018-11-23 | 2019-02-12 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | A kind of glucocorticoid immunochromatography wide spectrum detection card and the preparation method and application thereof |
CN109324183B (en) * | 2018-11-23 | 2022-03-29 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | Glucocorticoid immunochromatography broad-spectrum detection card and preparation method and application thereof |
CN116462729A (en) * | 2023-03-31 | 2023-07-21 | 华南农业大学 | Prednisone acetate hapten, artificial antigen and application thereof |
CN116462729B (en) * | 2023-03-31 | 2024-07-09 | 华南农业大学 | Prednisone acetate hapten, artificial antigen and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101949925B (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN201518027U (en) | Tetracycline immune colloidal gold quick test reagent board | |
CN103524427B (en) | Preparation method as well as application of trimethoprem hapten | |
CN103820394B (en) | Monoclonal antibodies against morphine, produce the cell strain of this antibody, morphine detection kit and preparation method thereof | |
CN101413943B (en) | Method for detecting melamine and specific enzyme-linked immunologic reagent kit | |
CN108139410A (en) | Improved Pregnancy Test device and method | |
CN1866014B (en) | Dot immunogold filtration assay kit for diagnosing cysticercosis cellulosae, preparation and application thereof | |
CN101533014A (en) | Colloidal gold chromatography test paper strip for quickly detecting bisphenol A and preparation method thereof | |
CN102288753A (en) | Quadruple colloidal gold immunochromatography testing strip for rapid detection of residual tetracycline, chlortetracycline, oxytetracycline and doxycycline and preparation method of same | |
CN102565382B (en) | Immunochromatography method for detecting allergen-specific IgE antibodies in blood samples | |
CN101980021A (en) | Colloidal gold chromatography test strip for quickly detecting sibutramine and derivative thereof and preparation method | |
CN101477124A (en) | Method for detecting melamine and its special test paper | |
CN103323592B (en) | High-throughput drug rapid detection chip and system | |
CN102435731A (en) | Viewable gold nanorod test strip for rapid detection of ochratoxin A and preparation method thereof | |
CN101144819B (en) | Colloidal gold test paper for detecting sulphaquinoxaline drug residue | |
CN101949925B (en) | Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method | |
CN102539786B (en) | Microscale urinary albumin colloidal gold detection kit and preparation technology thereof | |
CN105424937B (en) | A kind of progesterone colloidal gold immuno-chromatography test paper strip of monkey early pregnancy detection | |
CN103389379B (en) | A kind of detect tylosin and the test strips of tilmicosin and method | |
CN201269879Y (en) | Melamine detection test strip by color granule immunochromatography | |
CN103105490B (en) | A kind of kit and method detecting tetracycline medication | |
CN103376316A (en) | Test strip for detecting streptomycin and method | |
CN101986156A (en) | Colloidal gold chromatography test paper for detecting glibenclamide and derivatives of glibenclamide quickly and preparation method thereof | |
CN201181296Y (en) | Colloidal gold test paper card for detecting streptomycin medicine residue | |
CN101957376A (en) | Colloidal gold chromatography test paper for rapidly detecting guanidineacetic acid and derivatives thereof and preparation method thereof | |
CN105092863A (en) | In-vitro hemolytic test blood matching method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 226000 Jiangsu Province, Nantong City Lake Economic and Technological Development Zone, Road No. 1692 No. 15 building block A Patentee after: NANTONG EGENS BIOTECHNOLOGY CO., LTD. Address before: 226000 Jiangsu Province, Nantong City Lake Economic and Technological Development Zone, Road No. 1692 No. 15 building block A Patentee before: Nantong Egens Biotechnology Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method Effective date of registration: 20190109 Granted publication date: 20130731 Pledgee: Bank of China, Limited by Share Ltd, Nantong branch Pledgor: NANTONG EGENS BIOTECHNOLOGY CO., LTD. Registration number: 2019320000025 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200228 Granted publication date: 20130731 Pledgee: Bank of China, Limited by Share Ltd, Nantong branch Pledgor: NANTONG EGENS BIOTECHNOLOGY CO., LTD. Registration number: 2019320000025 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Colloidal gold chromatographic test strip for rapidly testing prednisone acetate and derivative thereof and preparation method Effective date of registration: 20200316 Granted publication date: 20130731 Pledgee: Bank of China, Limited by Share Ltd, Nantong branch Pledgor: NANTONG EGENS BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000726 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201224 Granted publication date: 20130731 Pledgee: Bank of China Limited by Share Ltd. Nantong branch Pledgor: NANTONG EGENS BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000726 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |